Journal of Pharmacovigilance and Drug Research最新文献

筛选
英文 中文
Teprotumumab-Associated Deafness: A Pharmacovigilance Analysis teprotumumab相关性耳聋:药物警戒分析
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-09-01 DOI: 10.53411/jpadr.2023.4.3.7
Mohini Bindal
{"title":"Teprotumumab-Associated Deafness: A Pharmacovigilance Analysis","authors":"Mohini Bindal","doi":"10.53411/jpadr.2023.4.3.7","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.3.7","url":null,"abstract":"","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"45 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114814154","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID pandemic: its impact on human health, environment, and potential strategies for sustanibility COVID - 19大流行:对人类健康、环境的影响以及可持续发展的潜在战略
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-09-01 DOI: 10.53411/jpadr.2023.4.3.3
Kamini Kashyap
{"title":"COVID pandemic: its impact on human health, environment, and potential strategies for sustanibility","authors":"Kamini Kashyap","doi":"10.53411/jpadr.2023.4.3.3","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.3.3","url":null,"abstract":"","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"112 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122820585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Essential Oil Components of Lemon grass leaves (Cymbopogon citratus) and its importance: A Narrative Review 柠檬草叶挥发油成分及其重要性综述
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-06-01 DOI: 10.53411/jpadr.2023.4.2.4
Juveriya Israr, I. Singh, H. Mishra, Smruti Mishra, Shabroz Alam, R. Krishna, K. Ahmad, H. Mehra, Goutam
{"title":"Essential Oil Components of Lemon grass leaves (Cymbopogon citratus) and its importance: A Narrative Review","authors":"Juveriya Israr, I. Singh, H. Mishra, Smruti Mishra, Shabroz Alam, R. Krishna, K. Ahmad, H. Mehra, Goutam","doi":"10.53411/jpadr.2023.4.2.4","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.2.4","url":null,"abstract":"Cymbopogon citratus, sometimes known as lemongrass, belongs to the Poaceae family. It is a medicinal plant that contains chemicals that can inhibit the growth of pathogens and boost the body's natural defenses against infectious disorders. Lemongrass is frequently used in baked goods, confections, herbal teas, and other non-alcoholic beverages. Lemongrass essential oil is frequently used as a scent in perfumes and beauty products like creams and soaps. The creation of beta carotene, and other nutrients is derived from citral, which is present in high concentrations in lemongrass essential oil. Lemon grass oil is therefore used in several pharmaceutical businesses for its anti-depressant, analgesic, antipyretic, bactericidal, and antiseptic properties due to the presence of diverse chemical elements.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"46 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131507561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Pharmacovigilance and Herbovigilance Regulatory Guidelines at the Global level 全球药物警戒和草药警戒管理指南的比较
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-06-01 DOI: 10.53411/jpadr.2023.4.2.3
Kumari Kajal
{"title":"Comparison of Pharmacovigilance and Herbovigilance Regulatory Guidelines at the Global level","authors":"Kumari Kajal","doi":"10.53411/jpadr.2023.4.2.3","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.2.3","url":null,"abstract":"Pharmacovigilance is the most cutting-edge technology in the medical field, the most advanced technologies in the medical field. It focuses on identifying, evaluating, analyzing, and preventing pharmacological side effects based on identification evaluation analysis and prevention of pharmacological side effects based on long-term and short-term drug exposure. Through the monitoring of drug safety, pharmacovigilance science seeks to enhance patient safety and population welfare.\u0000Every nation has regulatory organizations examining case reporting data and examines case reporting data and actual drug-related toxicological concerns. All adverse international unfavourable events in the country are centred at Uppsala Monitoring Centre (UMC). UMC determines judgments based on their investigation connected to numerous aspects of every case report, from Herbovigilance to the Pharmacovigilance drug program. The World Health Organization (WHO) was assisted by UMC when making worldwide decision-making on a global scale.\u0000 ","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"20 2 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133536676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofersen - A Ray of Hope for ALS Patients : A Mini Review Tofersen - ALS患者的一线希望:一个小回顾
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-06-01 DOI: 10.53411/jpadr.2023.4.2.1
H. Mishra
{"title":"Tofersen - A Ray of Hope for ALS Patients : A Mini Review","authors":"H. Mishra","doi":"10.53411/jpadr.2023.4.2.1","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.2.1","url":null,"abstract":"Despite thorough investigation, amyotrophic lateral sclerosis (ALS) continues to be adegenerative neurological condition that is inevitably fatal and progresses over time. The limitedunderstanding of the fundamental causes of ALS has posed challenges in addressing the initialbiological processes of the disease, resulting in therapeutic interventions typically being appliedat later stages of the illness.The existence of genetic variants in ALS presents a distinctive chance for advancing therapeuticapproaches, as studying genetic associations could unveil valuable information about the causesof the disease. In the case of genetic ALS, there is a possibility to explore early intervention byidentifying individuals who are at risk and have not yet shown symptoms but possess specificgenetic variations that contribute to the condition. Tofersen, an oligonucleotide, has beenspecifically created to diminish the production of superoxide dismutase 1 (SOD1) protein bybreaking down SOD1 mRNA.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"91 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122407918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluation of statin utilisation in tertiary care teaching hospital: An observational prospective study, YSR Kadapa 评价三级护理教学医院他汀类药物的使用:一项观察性前瞻性研究,YSR Kadapa
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-06-01 DOI: 10.53411/jpadr.2023.4.2.5
Suchitra Uppicherla, Divya Sree Tadimarri, Nandha Kumar K. N., Haritha Rajaboyna, K. D. Yadavendra Reddy, Gowtham Kumar Reddy Ponnolu, Rajaram Cuddapah, Jeevan Kumar B.
{"title":"Evaluation of statin utilisation in tertiary care teaching hospital: An observational prospective study, YSR Kadapa","authors":"Suchitra Uppicherla, Divya Sree Tadimarri, Nandha Kumar K. N., Haritha Rajaboyna, K. D. Yadavendra Reddy, Gowtham Kumar Reddy Ponnolu, Rajaram Cuddapah, Jeevan Kumar B.","doi":"10.53411/jpadr.2023.4.2.5","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.2.5","url":null,"abstract":"ABSTRACT;\u0000Introduction: Statins are highly preferred drugs in the treatment and prevention of atherosclerotic diseases. Statins usage increased in the last two decades. DUE is a cyclic quality-enhancing procedure in the prescription of drugs. Methods: Our study engaged in compiling various prescribing conditions for statins, assessing their effectiveness and safety, and comparing the lipid profile images of atorvastatin and rosuvastatin. A prospective observational study with the involvement of 150 volunteers The complete data collected is analysed using SAS and Microsoft Excel software. Statistical methods of mean, standard deviation, clinical significance, and Z value are calculated.\u0000Results: Atorvastatin (20 mg, 40 mg, and 80 mg) and Rosuvastatin (5 mg and 10mg) are widely used in the primary, secondary, and tertiary prevention of atherosclerotic cardiovascular and cerebrovascular problems. Average reduction of LDL and total cholesterol levels to 106.5(SD ±11.04) and 203.53 (SD±94) respectively.\u0000Key words: Atorvastatin, cardiovascular and cerebrovascular problems, non\u0000adherence, Re-occurrence, Rosuvastatin.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125943893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review on Pharmacovigilance perspective of the Pharmacopoeia’s and Formulary of Unani Medicine 《乌兰尼药典》及《乌兰尼药典》药物警戒视角综述
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-06-01 DOI: 10.53411/jpadr.2023.4.2.2
M. Quamri, Rabia N. Malik, A. Wadud
{"title":"Review on Pharmacovigilance perspective of the Pharmacopoeia’s and Formulary of Unani Medicine","authors":"M. Quamri, Rabia N. Malik, A. Wadud","doi":"10.53411/jpadr.2023.4.2.2","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.2.2","url":null,"abstract":"The aim of this review is to conceal the pharmacovigilance perspective of certain drugs of fourth degree potency, and substitutes in the preparation of formulations. Such drugs are dealt according to the standard procedures to make use of them, and use of appropriate substitutes in case of non-available drugs. Unani pharmacopeias and formularies have some drugs and dosage forms of concern with reference to pharmacovigilance","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"112 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117278013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxytocin induced itching in a 37 week primigravida with meconium stained liquor 催产素诱导胎粪染色液37周初产妇瘙痒
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-03-01 DOI: 10.53411/jpadr.2023.4.1.5
Disha Sai M Chandavar, Shiva Murthy Nanjundappa, D. P. Reddy, Dr. Nagendra Prasad N
{"title":"Oxytocin induced itching in a 37 week primigravida with meconium stained liquor","authors":"Disha Sai M Chandavar, Shiva Murthy Nanjundappa, D. P. Reddy, Dr. Nagendra Prasad N","doi":"10.53411/jpadr.2023.4.1.5","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.1.5","url":null,"abstract":"Introduction: Oxytocin is the most frequently used medication for labour augmentation in obstetrics. One of the known benefits of its use is the improvement of uterine contractions. An injectable form of oxytocin is administered intravenously as an infusion.  Adverse drug reactions at this stage may distress the baby and worsen the outcome of the pregnancy. \u0000Case details: A 19-year-old female with a history of nine months gestation presented in labour.  She was administered oxytocin infusion in ringer lactate to augment labor. She developed itching all over her body and was immediately administered Inj. hydrocortisone intravenously. As the foetus was in distress, she was taken for an emergency lower segment cesarean section (LSCS). \u0000Conclusion: The administration of IV oxytocin was considered the possible cause of the development of rashes in this case. We suggest adopting preventive strategies to avoid ADRs in emergencies to avoid deleterious consequences. The preventive strategies may include screening in the antenatal period for previous history of sensitivity to oxytocin, latex, etc. In addition, other strategies are discussed in this article.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116967757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of short-term COVID-19 vaccines adverse events following immunization severity as reported by Iraqi consumers 评估伊拉克消费者报告的免疫严重程度后短期COVID-19疫苗不良事件
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-03-01 DOI: 10.53411/jpadr.2023.4.1.2
Ban Al-Shimran, Manal Younus, Balqees Salih
{"title":"Evaluation of short-term COVID-19 vaccines adverse events following immunization severity as reported by Iraqi consumers","authors":"Ban Al-Shimran, Manal Younus, Balqees Salih","doi":"10.53411/jpadr.2023.4.1.2","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.1.2","url":null,"abstract":"Introduction: Consumer-generated Adverse Events Following Immunization (AEFI) reports are a major source of vaccine safety information in pharmacovigilance, which was unprecedented within the Iraqi settings. \u0000Methods: A self-assessment form was developed to be accessed by the consumers country-wide via the Iraqi pharmacovigilance center’s (IPvC) WhatsApp number. A retrospective analysis was then performed on the responses submitted from April 2021 until April 2022. Different independent variables were analyzed for their influence on subjective AEFI severity. \u0000Results: 2843 responses were finally included. The average number of reported AEFI was 4.03 (S.D. ± 2.58) per response and significantly different among vaccine types. Both Comirnaty and Vaxzevria-associated AEFIs were reported to affect daily life similarly (~59 %), while Sinopharm was 42.4 %. Treatment-seeking was highest in Vaxzervria reports (22.8 %). Factors associated with higher reported severity include; younger people, females, and previous COVID-19 infection. Also, for the Comirnaty vaccine, the second dose. Fever, body rash, and difficulty breathing were the most significantly associated with treatment-seeking. A very small number of serious AEFIs were also detected. \u0000Conclusion: Consumer reporting is valuable for generating data regarding COVID-19 vaccines’ AEFIs within the Iraqi spontaneous surveillance system and their engagement is recommended in the future for other medicinal products as well.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132593885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional survey to assess the efficacy of home remedies during Covid times from a Pharmacovigilance perspective 从药物警戒角度评估Covid期间家庭疗法疗效的横断面调查
Journal of Pharmacovigilance and Drug Research Pub Date : 2023-03-01 DOI: 10.53411/jpadr.2023.4.1.3
Shubhashree Mn, Raghavenda Naik, C. Chandrasekharan, S. Bhat
{"title":"A cross-sectional survey to assess the efficacy of home remedies during Covid times from a Pharmacovigilance perspective","authors":"Shubhashree Mn, Raghavenda Naik, C. Chandrasekharan, S. Bhat","doi":"10.53411/jpadr.2023.4.1.3","DOIUrl":"https://doi.org/10.53411/jpadr.2023.4.1.3","url":null,"abstract":"Introduction: Many strategies have been suggested for the prevention of COVID-19 such as the intake of certain home remedies. \u0000Objectives: To assess the efficacy of home remedies like Kadha (Decoction) consumed during covid times and document the adverse events if any due to indiscriminate use of home remedies. \u0000To document various home remedies used by the public to boost immunity. \u0000Method: About 130 patients who attended the OPD at Central Ayurveda Research Institute (CARI), Bengaluru were included in the survey by using a questionnaire. The questionnaire was prepared to collect information regarding the intake, type, duration, and benefits of home remedies. \u0000Results: It was observed that a majority of the participants in the study were not aware of the long-term consequences of consuming a particular home remedy. Due to the fear of covid and faith in home remedies, many opted for a preventive measure. Ginger was the most frequently used drug as a home remedy and hyperacidity with heartburn was the most common untoward effect observed due to the inappropriate use of the home remedies. \u0000Conclusion: Ayurveda emphasizes diet and regimen as a part of the treatment along with Aushadha Sevana Kaala (the time of administration of medicine). When home remedies are consumed without medical supervision and without adhering to the basic principles as cautioned in Ayurvedic medicine, it is bound to cause some untoward effects. This study is a humble attempt in this direction.","PeriodicalId":388338,"journal":{"name":"Journal of Pharmacovigilance and Drug Research","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125124447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信